Dr. Alphonse Taghian from Massachusetts General Hospital (MGH) in Boston, USA, will discuss hypofractionated radiotherapy [HYPO-RT] in breast cancer. Join us as Dr. Taghian explores how this treatment approach represents a shift in paradigm, offering new possibilities for patients. Gain insights into the benefits and considerations of HYPO-RT and its implications for breast cancer management.